Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
5
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
5
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
5
×
clinical trials
deals
startups
vertex pharmaceuticals
cancer immunotherapy
fda
pfizer
president trump
takeda pharmaceutical
aduro biotech
What
roundup
bio
drug
ahead
asco
days
plan
advantages
alliance
alzheimer’s
ambien
american
annual
attendees
attention
bar
biotech
branded
brings
bristol
buy
calls
camp’s
cancer
cash
changing
chicago
choices
city
clinical
color
combinations
commissioner
community’s
companies
consumers
costly
counterweight
crispr
different
Language
unset
Current search:
roche
×
investing
×
" wisconsin top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
